查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654223

光化性角化症治療市場規模、佔有率、趨勢分析報告，分類：治療方法、藥物類別、最終用途、地區、細分預測，2025-2030 年

Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical, Surgery, Photodynamic Therapy), By Drug Class (NSAIDs), By End use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

光化性角化症治療市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球光化性角化症治療市場規模預計到2030年將達到89.3億美元，2025年至2030年複合年成長率為4.1%。

由於用於治療光化性角化病的藥物廣泛可用、人們對該疾病的認知不斷提高以及 AK 治療的數量不斷增加等因素，預計市場將迎來成長機會。此外，預計預測期內光化性角化病患病率的增加和全球老年人口的增加將推動市場成長。

侵襲性鱗狀細胞癌可由 AK 的惡性轉化 (iSCC) 發展而來。 iSCC 有幾種潛在病因，但 AK 是最常見的原因之一。此外，基底細胞癌和非黑色素瘤皮膚癌也可能由 AK 引起。因此，無論銷售管道如何，對 AK 產品的需求都是由對光化性角化病的早期診斷和治療作為預防併發症的策略所推動的。

此外，未來藥物和聯合治療的興起也在推動市場的發展。例如，Almirall, SA 的 Klisyri（擴大適應症）處於 III 期研發階段。此外，創新藥物的接受度和商業化的提高也有望推動市場成長。此外，研發活動的活性化預計將加速治療光化性角化症的新藥的核准，從而推動預測期內的成長。

主要企業正在採取產品發布、合作夥伴關係和擴大策略等策略性舉措，以增加市場佔有率。例如，2022 年 6 月，BIOFRONTERA AG 宣布瑞士的 Louis Widmer SA 已獲得 Ameluz 用於治療身體軀幹、四肢和頸部光化性角化病的行銷核准延長。此外，2020 年 7 月，BIOFRONTERA AG 宣布與 Galenica AB 簽署協議，在挪威、芬蘭、挪威和冰島分銷 BF-RhodoLED 和 Ameluz。

光化性角化症治療市場報告重點：

  • 由於冷凍療法手術在治療光化性角化症的應用越來越多，預計到 2024 年手術將佔據最大的收入佔有率，達到 63.8%。
  • 核苷代謝抑制劑在 2024 年佔據了最大的收益佔有率，預計在預測期內仍將保持主導地位。
  • 預計亞太地區將以最快的速度成長，預測期內複合年成長率為 5.4%，這歸因於 AK 患病率高、醫療保健基礎設施快速發展以及亞太國家醫療保健支出不斷增加等因素。
  • 由於人們對光化性角化病的認知不斷提高、強大治療方案的可用性以及醫療保健基礎設施的不斷改善，北美在 2024 年佔據了市場主導地位，收入佔有率最大，為 40.5%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 光化性角化症治療市場變數、趨勢與範圍

  • 市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第 4 章 光化性角化症治療市場：治療方法業務分析

  • 2024 年和 2030 年治療方法市場佔有率
  • 治療方法細分儀表板
  • 2018 年至 2030 年按治療方法的市場規模、預測與趨勢分析
  • 局部的
  • 外科手術
  • 動態療法

第5章 光化性角化症治療市場-藥物類別業務分析

  • 2024 年及 2030 年藥物類別市場佔有率
  • 藥品類別細分儀表板
  • 2018 年至 2030 年按藥物類別分類的市場規模、預測和趨勢分析
  • 核苷代謝抑制劑
  • NSAIDs
  • 免疫反應調節劑
  • 光增強劑
  • 其他

6. 光化性角化症治療市場-最終用途業務分析

  • 2024 年及 2030 年終端用途市場佔有率
  • 最終用途細分儀表板
  • 2018 年至 2030 年按最終用途分類的市場規模、預測和趨勢分析
  • 醫院
  • 私人診所
  • 居家護理
  • 其他

第7章 光化性角化症治療市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018 年至 2030 年市場規模及預測趨勢分析：
  • 北美洲
    • 按國家
    • 美國
    • 加拿大
  • 歐洲
    • 按國家
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 按國家
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 按國家
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第8章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Almirall, SA
    • LEO Pharma A/S
    • Sun Pharmaceutical Industries Ltd.
    • Novartis AG
    • Galderma
    • Ortho Dermatologics（Bausch Health Companies Inc.）
    • BIOFRONTERA Inc
    • Hill Dermaceuticals, Inc
    • 3M
    • Alma Lasers
Product Code: GVR-2-68038-940-1

Actinic Keratosis Treatment Market Growth & Trends:

The global actinic keratosis treatment market size is expected to reach USD 8.93 billion by 2030, registering a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness growth opportunities owing to factors such as the wide availability of actinic keratosis therapeutics, rising awareness about the disease, and the rise in AK treatment. Moreover, the increasing prevalence of actinic keratosis and the rising geriatric population across the globe are expected to fuel the market growth during the forecast period.

Invasive squamous cell carcinoma may develop from AK when it becomes malignant (iSCC). Despite the fact that there are a number of potential causes for iSCC, AK is one of the most frequent ones. Additionally, basal cell carcinoma and non-melanoma skin cancer could result from AK. As a result, the demand for AK products across sales channels is being driven by the early diagnosis and treatment of actinic keratosis as a preventive strategy for comorbidities.

In addition, future pipeline medications and the increased use of combination therapy are key market drivers. For instance, Almirall, S.A. has Klisyri (extended label) in phase III of R&D. Furthermore, a rise in the acceptance and commercialization of innovative drugs is another factor that is predicted to fuel market growth. Moreover, increased R&D activities are expected to accelerate the approval of novel drugs used in the treatment of actinic keratosis, hence, propelling the growth over the forecast period.

Key players are adopting strategic initiatives such as product launches, partnerships, and expansion strategies to increase their market share across the globe. For instance, in June 2022, BIOFRONTERA AG announced that its license and marketing authorization holder Louis Widmer SA based in Switzerland has received an extension of its marketing authorization for the management of actinic keratosis in the trunk, extremities, and neck with Ameluz. Moreover, in July 2020, BIOFRONTERA AG announced that it has signed an agreement with Galenica AB for the marketing of BF-RhodoLED and Ameluz in Norway, Finland, and Iceland.

Actinic Keratosis Treatment Market Report Highlights:

  • Surgery held the largest revenue share of 63.8% in 2024 owing to the rising adoption of cryotherapy surgery in the management of actinic keratosis
  • Nucleoside metabolic inhibitors held the largest revenue share in 2024 and is expected to retain its dominance over the forecast period
  • Asia Pacific is expected to grow at the fastest CAGR of 5.4% during the forecast period due to factors such as the high prevalence of AK, rapidly evolving healthcare infrastructure, and rising healthcare expenditures by Asia Pacific countries
  • North America dominated the market with the largest revenue share of 40.5% in 2024 due to the rising awareness among people about actinic keratosis, availability of robust treatment options, and improvements in healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Therapy
    • 1.2.2. Drug Class
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Actinic Keratosis Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Actinic Keratosis Treatment Market: Therapy Business Analysis

  • 4.1. Therapy Market Share, 2024 & 2030
  • 4.2. Therapy Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
  • 4.4. Topical
    • 4.4.1. Topical Market, 2018 - 2030 (USD Million)
  • 4.5. Surgery
    • 4.5.1. Surgery Market, 2018 - 2030 (USD Million)
  • 4.6. Photodynamic Therapy
    • 4.6.1. Photodynamic Therapy Market, 2018 - 2030 (USD Million)

Chapter 5. Actinic Keratosis Treatment Market: Drug Class Business Analysis

  • 5.1. Drug Class Market Share, 2024 & 2030
  • 5.2. Drug Class Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
  • 5.4. Nucleoside Metabolic Inhibitor
    • 5.4.1. Nucleoside Metabolic Inhibitor Market, 2018 - 2030 (USD Million)
  • 5.5. NSAIDs
    • 5.5.1. NSAIDs Market, 2018 - 2030 (USD Million)
  • 5.6. Immune Response Modifiers
    • 5.6.1. Immune Response Modifiers Market, 2018 - 2030 (USD Million)
  • 5.7. Photoenhancers
    • 5.7.1. Photoenhancers Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Actinic Keratosis Treatment Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.5. Private Clinics
    • 6.5.1. Private Clinics Market, 2018 - 2030 (USD Million)
  • 6.6. Homecare
    • 6.6.1. Homecare Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Actinic Keratosis Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Actinic Keratosis Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Actinic Keratosis Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Actinic Keratosis Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Mexico
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Mexico Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. Argentina
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Framework
      • 7.7.4.3. Competitive Insights
      • 7.7.4.4. Argentina Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Actinic Keratosis Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Actinic Keratosis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Almirall, S.A
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. LEO Pharma A/S
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Sun Pharmaceutical Industries Ltd.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Novartis AG
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Galderma
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Ortho Dermatologics (Bausch Health Companies Inc.)
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. BIOFRONTERA Inc
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Hill Dermaceuticals, Inc
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. 3M
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Alma Lasers
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 5 Global actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 6 Global actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America actinic keratosis treatment market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 9 North America actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 10 North America actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 12 U.S. actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 13 U.S. actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 15 Canada actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 16 Canada actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Europe actinic keratosis treatment market, by country, 2018 - 2030 (USD Million)
  • Table 18 Europe actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 19 Europe actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 20 Europe actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 21 UK actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 22 UK actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 23 UK actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 25 Germany actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 26 Germany actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 27 France actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 28 France actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 29 France actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Italy actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 31 Italy actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 32 Italy actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Spain actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 34 Spain actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 35 Spain actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific actinic keratosis treatment market, by country, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Japan actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 41 Japan actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 42 Japan actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 43 China actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 44 China actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 45 China actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 46 India actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 47 India actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 48 India actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 49 South Korea actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 50 South Korea actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 51 South Korea actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Australia actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 53 Australia actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 54 Australia actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Latin America actinic keratosis treatment market, by country, 2018 - 2030 (USD Million)
  • Table 56 Latin America actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 57 Latin America actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 58 Latin America actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Brazil actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 60 Brazil actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 61 Brazil actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Mexico actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 63 Mexico actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 64 Mexico actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Argentina actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 66 Argentina actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 67 Argentina actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Middle East & Africa actinic keratosis treatment market, by country, 2018 - 2030 (USD Million)
  • Table 69 Middle East & Africa actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 70 Middle East & Africa actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 71 Middle East & Africa actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 72 South Africa actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 73 South Africa actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 74 South Africa actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Saudi Arabia actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 76 Saudi Arabia actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 78 UAE actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
  • Table 79 UAE actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 80 UAE actinic keratosis treatment market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Actinic keratosis treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapy outlook (USD Million)
  • Fig. 10 Drug class outlook (USD Million)
  • Fig. 11 End use outlook (USD Million)
  • Fig. 12 Competitive landscape
  • Fig. 13 Actinic keratosis treatment market dynamics
  • Fig. 14 Actinic keratosis treatment market: Porter's five forces analysis
  • Fig. 15 Actinic keratosis treatment market: PESTLE analysis
  • Fig. 16 Actinic keratosis treatment market: Therapy segment dashboard
  • Fig. 17 Actinic keratosis treatment market: Therapy market share analysis, 2024 & 2030
  • Fig. 18 Topical market, 2018 - 2030 (USD Million)
  • Fig. 19 Surgery market, 2018 - 2030 (USD Million)
  • Fig. 20 Photodynamic therapy market, 2018 - 2030 (USD Million)
  • Fig. 21 Actinic keratosis treatment market: Drug class segment dashboard
  • Fig. 22 Actinic keratosis treatment market: Drug class market share analysis, 2024 & 2030
  • Fig. 23 Nucleoside metabolic inhibitor market, 2018 - 2030 (USD Million)
  • Fig. 24 NSAIDs market, 2018 - 2030 (USD Million)
  • Fig. 25 Immune response modifiers market, 2018 - 2030 (USD Million)
  • Fig. 26 Photoenhancers market, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Actinic keratosis treatment market: End use segment dashboard
  • Fig. 29 Actinic keratosis treatment market: End use market share analysis, 2024 & 2030
  • Fig. 30 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 31 Private clinics market, 2018 - 2030 (USD Million)
  • Fig. 32 Homecare market, 2018 - 2030 (USD Million)
  • Fig. 33 Others market, 2018 - 2030 (USD Million)
  • Fig. 34 Actinic keratosis treatment market revenue, by region
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 North America actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. country dynamics
  • Fig. 38 U.S. actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada country dynamics
  • Fig. 40 Canada actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 UK country dynamics
  • Fig. 43 UK actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany country dynamics
  • Fig. 45 Germany actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 France country dynamics
  • Fig. 47 France actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy country dynamics
  • Fig. 49 Italy actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain country dynamics
  • Fig. 51 Spain actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan country dynamics
  • Fig. 54 Japan actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 China country dynamics
  • Fig. 56 China actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 India country dynamics
  • Fig. 58 India actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea country dynamics
  • Fig. 60 South Korea actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia country dynamics
  • Fig. 62 Australia actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil country dynamics
  • Fig. 65 Brazil actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico country dynamics
  • Fig. 67 Mexico actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina country dynamics
  • Fig. 69 Argentina actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 MEA actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa country dynamics
  • Fig. 72 South Africa actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia country dynamics
  • Fig. 74 Saudi Arabia actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE country dynamics
  • Fig. 76 UAE actinic keratosis treatment market, 2018 - 2030 (USD Million)
  • Fig. 77 Company categorization
  • Fig. 78 Company market position analysis
  • Fig. 79 Strategic framework